ATLASense Biomed is an Israeli-based company specializing in advanced medical monitoring technologies. Their flagship product, REPHAEL, is the world’s first wearable device that delivers ICU-level telemetry both at home and in hospital settings. REPHAEL not only monitors but also predicts, detects, and alerts users to life-threatening conditions such as respiratory failure, heart failure, sepsis, and falls, enabling early preventive action. This non-invasive, AI-driven platform empowers healthcare systems to provide exceptional care from the comfort of home, reducing hospital admissions and significantly cutting healthcare costs.